Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Low Dose Ketamine Versus Morphine for Moderate to Severe Pain in the Emergency Department: A Prospective, Randomized, Double-Blind Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01835262

Organisation Name: Maimonides Medical Center

Overal Status: Completed

Start Date: April 2013

Last Update: February 29, 2016

Lead Sponsor: Antonios Likourezos

Brief Summary: The primary objectives of the study are to evaluate the efficacy of subdissociative dose intravenous ketamine compared with intravenous morphine in relieving acute pain in the ED. Secondary objectives will include the rate of adverse effects and need for rescue analgesia. The hypothesis is that intravenous administration of subdissociative dose ketamine at 0.3 mg/kg is superior to intravenous morphine at 0.1mg/kg in treating moderate and severe acute pain in patients presenting to the ED.

Conditions:
  • Pain


Total execution time in seconds: 0.21149015426636